alexa Abstract | Synthesis, characterization, anti-angiogenic and anti-oxidant activities of 1,5-benzothiazepin-4-(5H)-one derivatives

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access

Abstract

New 1,5-benzothiazepin-4-(5H)-one derivatives (9a-9e) have been synthesized. The anti-angiogenic and antioxidant properties of the new derivatives were then evaluated. All the compounds (9a-9e) exhibited very good inhibition of capillary proliferation, thus proving their anti-angiogenic properties. In addition, the in vitro antioxidant activities of these compounds were evaluated using diphenyl picryl hydrazine (DPPH), and NO (nitric oxide) assays, and the results were compared with butylated hydroxytoluene (BHT), a well known anti-oxidant. Compounds (9a-9e) showed excellent free-radical scavenging activities in the nitric oxide assay, thus proving to be more potent than BHT.

To read the full article Peer-reviewed Article PDF image

Author(s): Channegowda V Deepua Nanjappagowda D Rekhab Goravanahalli M Raghavendracand Doddamedur G Bhadregowdaa

Keywords

1,5-benzothiazepin-4-(5H)-one, Anti-Angiogenic, Anti-oxidants, Suzuki coupling, anti-angiogenic

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords